Benadryl for Acute Migraine Treatment
Benadryl (diphenhydramine) should NOT be used as a primary treatment for acute migraine, as it provides no benefit when added to standard migraine therapy. The most recent 2025 American College of Physicians guidelines do not recommend diphenhydramine for acute migraine treatment, and high-quality research demonstrates it is ineffective 1.
Evidence Against Diphenhydramine as Migraine Treatment
The strongest evidence comes from a 2016 randomized controlled trial that directly tested whether adding diphenhydramine 50 mg IV to metoclopramide 10 mg IV improved migraine outcomes compared to metoclopramide alone 2. The study was halted early for futility after enrolling 208 patients:
- Sustained headache relief at 48 hours: 40% with diphenhydramine vs 37% with placebo (no meaningful difference)
- Pain improvement at 1 hour: 5.1 points vs 4.8 points on 0-10 scale (clinically insignificant)
- No reduction in adverse effects, including akathisia rates
This definitively shows diphenhydramine adds nothing to migraine treatment efficacy 2.
The Akathisia Prevention Myth
Diphenhydramine is commonly given with dopamine antagonists (like prochlorperazine or metoclopramide) under the belief it prevents akathisia. However:
- A 2023 systematic review found insufficient evidence that diphenhydramine prevents akathisia in headache patients (RR 0.83,95% CI 0.43-1.61) 3
- A 2024 pediatric study showed no association between diphenhydramine use and treatment outcomes, though extrapyramidal effects were rare in both groups 4
The routine prophylactic use of diphenhydramine to prevent akathisia is not evidence-based.
What Actually Works: The Evidence-Based Algorithm
Based on the 2025 ACP guidelines 1:
For Moderate to Severe Migraine:
First-line: Triptan + NSAID (or triptan + acetaminophen if NSAIDs contraindicated)
- Start treatment as soon as migraine begins
- This combination therapy is superior to monotherapy
If inadequate response: Try a different triptan or NSAID within the same class
If triptan + NSAID fails: Consider CGRP antagonists (rimegepant, ubrogepant, zavegepant) or dihydroergotamine
Last resort: Lasmiditan for patients who fail all other treatments
For Mild Migraine:
- NSAID alone, acetaminophen alone, or their combination
What NOT to Use:
- Opioids (including hydromorphone, which was shown inferior to prochlorperazine in a 2017 RCT 5)
- Butalbital
- Diphenhydramine as primary or adjunctive therapy
Special Situations
For severe nausea/vomiting: Use a nonoral triptan with an antiemetic (prochlorperazine or metoclopramide are effective dopamine antagonists that also treat migraine) 1.
Critical Pitfalls to Avoid
- Medication overuse headache: Occurs with ≥10 days/month of triptan use or ≥15 days/month of NSAID use 1
- Adding diphenhydramine unnecessarily: Increases sedation without improving outcomes or preventing akathisia 2, 3
- Using opioids: Substantially less effective than dopamine antagonists (31% vs 60% sustained relief) 5
Bottom line: Diphenhydramine has no role in acute migraine treatment based on current evidence. Stick to the proven algorithm of triptans combined with NSAIDs or acetaminophen as first-line therapy.